Drug Type Small molecule drug |
Synonyms PF 232798, PF-00232798 |
Target |
Action antagonists |
Mechanism CCR5 antagonists(C-C chemokine receptor type 5 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H40FN5O2 |
InChIKeyQETUKYDWZIRTEI-QUMGSSFMSA-N |
CAS Registry849753-15-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 2 | Germany | 01 Jun 2007 | |
Arrhythmias, Cardiac | Phase 1 | Singapore | 01 Jul 2010 | |
Arrhythmias, Cardiac | Phase 1 | Singapore | 01 Jul 2010 |
Phase 2 | 43 | (PF-00232798 5 mg) | nqyomdvlxd(uvdssmqvhr) = gyekopqdrw joahxfdjzp (mqjhmlglgr, 0.3075) View more | - | 30 Oct 2013 | ||
(PF-00232798 20 mg) | nqyomdvlxd(uvdssmqvhr) = hfuysnihjv joahxfdjzp (mqjhmlglgr, 0.4753) View more |